2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 30ÀÏ : 2019-08-30±³À°ÀÏÀÚ : 2019-08-30
±³À°Àå¼Ò : º¤½ºÄÚ ROOM A ¿Ü
±³À°ÁÖÁ¦ :
2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 30ÀÏÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : ±èÈñÀç
¿¬¶ôó : 02-6711-5006
À̸ÞÀÏ :
apbmt.icbmt2019@gmail.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í Àü¹®ÀÇ 150,000¿ø, Çлý/°£È£»ç/¿¬±¸¿ø/±âŸ 80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-30 ROOM A 09:30~09:50 GVHD prophylaxis with post CY after haplo-identical , matched unelated, and HLA-identical stem cell transplantation Nicolaus Kröger(University Hospital Hamburg / Berman Germany)
±³À°½Ã°£ 08-30 ROOM A 09:50~10:10 Future changes in Stem Cell Transplantation and Cellular Therapy: Safer, Less toxic and Less Costly approaches Daniel Weisdorf(University of Minnesota USA)
±³À°½Ã°£ 08-30 ROOM A 10:10~10:30 Novel approaches for treating and preventing GvHD John F. DiPersio(Washington University School of Medicine USA)
±³À°½Ã°£ 08-30 ROOM A 10:30~10:50 Design the future of hematopoietic cell transplantation in Asia-Pacific countries/regions Shinichiro Okamoto(Keio University Japan)
±³À°½Ã°£ 08-30 ROOM A 11:00~11:40 HSC genetic modification to model human diseases and develop new therapy Cynthia E. Dunbar(NIH/NHLBI USA)
±³À°½Ã°£ 08-30 ROOM A 11:40~12:20 Outcome of unmanipulated haploidentical transplants in leukemia : an update on 500 patients Andrea Bacigalupo(Universitario Gemelli IRCCS Universita Italy)
±³À°½Ã°£ 08-30 ROOM A 12:30~13:30 Recent Advances in the Treatment of Immune Thrombocytopenia with TPO Receptor Agonists David Kuter(Massachusetts General Hospital USA)
±³À°½Ã°£ 08-30 ROOM A 13:30~14:00 Flow cytometry, as fast and effective tool for monitoring of Hyper-IgM syndrome in a 13-month-old young boy with hematopoietic stem cell transplantation Kyung Mi Park(Pusan National University)
±³À°½Ã°£ 08-30 ROOM B 14:30~15:00 Identification of high-risk AML Hiroki Yamaguchi(Univeristy of Tokyo Japan)
±³À°½Ã°£ 08-30 ROOM B 15:00~15:30 Prediction of post-SCT outcome Je-Hwan Lee(University of Ulsan)
±³À°½Ã°£ 08-30 ROOM B 15:30~16:00 Personalized application of SCT for adult AML Shingo Yano(Jikei University Japan)
±³À°½Ã°£ 08-30 ROOM B 16:00~16:30 Tailored therapy for pediatric AML Jae Wook Lee(The Catholic University of Korea)
±³À°½Ã°£ 08-30 ROOM B 17:00~17:30 Pros and cons on the role of upfront auto-SCT for peripheral T-cell lymphoma Lim Soon Thye(National Cancer Centre Singapore)
±³À°½Ã°£ 08-30 ROOM B 17:30~18:00 Pros and cons on the role of upfront auto-SCT for primary CNS lymphoma Dok Hyun Yoon(University of Ulsan)